Peter H. Gilligan
- Infectious Diseases top 0.2%
- Clostridium difficile and Clostridium perfringens research 19
- Viral gastroenteritis research and epidemiology 18
- Antimicrobial Resistance in Staphylococcus 15
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 20
- Molecular Medicine top 0.5%
- Endocrinology top 0.5%
- Microbiology top 0.5%
-
- Cystic Fibrosis Research Advances 35
-
- Mycobacterium research and diagnosis 19
- Pneumonia and Respiratory Infections 11
-
- Streptococcal Infections and Treatments 15
- Co-authors
- Richard S. SchwalbeJack T. StapletonLawrence J. BrandtLynne V. McFarlandAshwin N. AnanthakrishnanChristina M. SurawiczDavid G. BinionBrian S. Zuckerbraun
- Journals
- New England Journal of Medicine (3 papers)Journal of Clinical Oncology (1 paper)Applied and Environmental Microbiology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter H. Gilligan
126 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Infectious Diseases 3.5k
- Clinical Biochemistry 1.0k
- Molecular Medicine 745
- Endocrinology 672
- Microbiology 98
Countries citing papers authored by Peter H. Gilligan
This map shows the geographic impact of Peter H. Gilligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Gilligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Gilligan more than expected).
Fields of papers citing papers by Peter H. Gilligan
This network shows the impact of papers produced by Peter H. Gilligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Gilligan. The network helps show where Peter H. Gilligan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter H. Gilligan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2019 | 30 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 61 | |
| 5 | 2017 | 23 | |
| 6 | 2016 | 11 | |
| 7 | 2015 | 11 | |
| 8 | 2013 | 70 | |
| 9 | 2010 | 291 | |
| 10 | 2010 | 18 | |
| 11 | 2005 | 1 | |
| 12 | 2002 | 153 | |
| 13 | 2002 | 30 | |
| 14 | 2001 | 177 | |
| 15 | 2000 | 193 | |
| 16 | 1997 | 106 | |
| 17 | 1993 | 20 | |
| 18 | 1992 | 125 | |
| 19 | 1991 | 13 | |
| 20 | 1990 | 7 |
About Peter H. Gilligan
Peter H. Gilligan is a scholar working on Microbiology, Endocrinology and Clinical Biochemistry, having authored 132 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (35 papers), Bacterial Identification and Susceptibility Testing (20 papers), Mycobacterium research and diagnosis (19 papers), Clostridium difficile and Clostridium perfringens research (19 papers), Viral gastroenteritis research and epidemiology (18 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Streptococcal Infections and Treatments (15 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Infectious Diseases (3.5k citations), Clinical Biochemistry (1.0k citations) and Molecular Medicine (745 citations). Peter H. Gilligan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard S. Schwalbe, Jack T. Stapleton, Lawrence J. Brandt, Lynne V. McFarland, Ashwin N. Ananthakrishnan, Christina M. Surawicz, David G. Binion, Brian S. Zuckerbraun, Mark Mellow and Scott Curry. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.